Drug Shortage Report for ZEMURON
Report ID | 3193 |
Drug Identification Number | 02108208 |
Brand name | ZEMURON |
Common or Proper name | ZEMURON Solution for Injection |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ROCURONIUM BROMIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 5 mL vials |
ATC code | M03AC |
ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2017-07-31 |
Actual start date | |
Estimated end date | |
Actual end date | 2017-07-14 |
Shortage status | Avoided shortage |
Updated date | 2017-07-17 |
Company comments | Business reasons |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-17 | English | Compare |
v2 | 2017-03-17 | French | Compare |
v3 | 2017-03-17 | English | Compare |
v4 | 2017-03-17 | French | Compare |
v5 | 2017-03-28 | English | Compare |
v6 | 2017-03-28 | French | Compare |
v7 | 2017-07-17 | English | Compare |
v8 | 2017-07-17 | French | Compare |
Showing 1 to 8 of 8